Research Article
Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer
Table 5
Correlation between clinical pathology and neoadjuvant efficacy before neoadjuvant therapy (baseline).
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
When (two-tailed) or (two-tailed), it indicated a significant correlation. CTC, circulating tumor cell; PR, partial response; SD, stable disease; PD, progressive disease; and N, case number. |